Positive correlations between the expression level of Nanog and malignancy were observed in 14 types of cancer, including breast cancer, colon cancer, embryonic carcinoma, liver cancer, and skin cancer (melanoma) [12,13,14]. This evidence concerns the gene NANOG and malignant colon neoplasm.